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Background: With hypertension, the cardiovascular system changes to adapt to the varying neuro-humoral and
hemodynamic changes and this may lead to the development of different left ventricular geometric patterns, each
carrying a different risk profile for major adverse cardiovascular events.
Methods: Using a consecutive sampling technique, a cross-sectional, prospective, hospital based study was done
and two hundred and twenty seven (227) hypertensive patients were studied.
Results: The distribution of different abnormal LV geometrical patterns was 19.8%, 28.2%, 22% for concentric
remodelling, concentric hypertrophy and eccentric hypertrophy respectively. With echocardiographic criteria, the
proportion of patients with left ventricular hypertrophy (LVH) was higher when left ventricular mass (LVM) was
indexed to height2.7 than to body surface area (70.0% vs. 52.9%). Duration of hypertension markedly influenced the
type of LV geometry with normal LV geometry predominating in early hypertension and abnormal geometrical
patterns predominating in late hypertension. The left ventricular fractional shortening decreased with duration of
hypertension and was common in patients with eccentric hypertrophy. Age of the patient, systolic blood pressure,
duration of hypertension and body mass index were found to be independent predictors left ventricular
hypertrophy.
Conclusion: About 70% of hypertensive patients had abnormal geometry existing in different patterns. Eccentric
hypertrophy had more of clinical and echocardiographic features suggestive of reduced left ventricular systolic
function. Hypertensive patients should be recognized as a heterogeneous population and therefore stratifying them
into their respective LV geometrical patterns is useful as way of assessing their risk profile as well as instituting
appropriate management.
Keywords: Echocardiography, Essential hypertension, Left ventricular hypertrophy, Left ventricular geometry, Left
ventricular mass index, Left ventricular functionBackground
The World Health Organization (WHO) reported that
non-communicable diseases accounted for 60% of the
world's total deaths, and about 80% of these are occur-
ring in the developing countries [1]. In Africa, cardio-
vascular disease is no longer an emerging problem, but* Correspondence: lasikoki@gmail.com
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reproduction in any medium, provided the orhas become firmly established and its magnitude is
approaching that of an epidemic [2].
There are many conditions that are known to increase
risk of cardiovascular diseases but hypertension has long
been known explicitly to be a strong and independent
risk factor for the development of major adverse cardio-
vascular events, whereby the cardiovascular system
adopts different abnormal changes as a result of long
standing hypertension [3]. The heart adaptation to these
changes includes geometrical re-orientation in different
patterns notably concentric remodelling, concentricl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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geometric pattern is determined mainly by the predo-
minating type of stressor/stimulus to the myocardium, i.e.
volume overload or pressure overload [5,6]. With time
due to unknown factors these changes become maladap-
tive and predispose patients to major adverse cardiovascu-
lar events. The risks vary from one patient to another
depending on the type and severity of change.
World Health Organization (WHO) defines hyperten-
sion as a chronic medical condition in which the arterial
blood pressure is elevated ≥140 mmHg systolic and/or ≥90
mmHg diastolic on two readings taken apart or a reported
diagnosis of hypertension and treatment with recognized
anti- hypertensive within 2 weeks before the visit. In a
cross-sectional study involving three Sub-Saharan African
countries (Tanzania, Malawi and Rwanda), together, the
prevalence of hypertension and pre-hypertension was
found to be 22 and 44% respectively [7].
The definition and criteria of left ventricular hyper-
trophy (LVH) are variable in many studies [8]. The diag-
nosis of LVH has been incorporated in clinical practice
as an important marker of cardiovascular disease. Its
prevalence depends on classification criteria and specific
population characteristics, ranging from 3% in normo-
tensive community based samples [9] to about three-
quarters of hypertensive patients [10].
Methods
Study population
The study population included adult patients firmly
diagnosed to have essential arterial hypertension with or
without treatment. A consecutive sampling method was
used. We excluded patients who had poor quality of
echocardiography imaging due to various reasons in-
cluding obesity and lung problems. Patients noted to
have impaired global or segmental wall motion and
valvular lesions during echocardiography examination
were excluded. Also patients with suspected or esta-
blished secondary hypertension were also excluded.
Study procedures
During recruitment, the principal investigator (PI) filled
in a standardized structured questionnaire for each pa-
tient included in the study. A detailed history was
obtained from the patient or from a close relative and
recorded in the patient case-note and in the structured
questionnaire. Physical examination findings, electrocar-
diogram and echocardiogram results were recorded in
the data collection sheet.
Patient evaluation: history and physical examination
A thorough and detailed history was taken and in par-
ticular the history focused on presence or absence ofovert heart-related symptoms. Duration of hypertension
was also noted.
Socio-demographic data, anthropometric and biome-
tric measurements were taken: – Height (in meters) was
taken using a commercially available stadiometer and
the patient was required to stand upright away from but
body and head touching the meter ruler (m). Weight
(in kilograms) was taken using a standard weighing scale
to the nearest rounded value while the patient is in light
clothing and shoes taken off.
A thorough general examination was conducted to
each patient and vital signs obtained. Blood pressure
measurement using standard well calibrated mercury
sphygnomanometer based was taken.
The body mass index (BMI) was derived by dividing
the weight (kg) by the square of the height (m) and
classification of obesity was done according to WHO
criteria. The body surface area (BSA) was calculated
using the formula derived by Du Bois and Du Bois
(1929) as: BSA = (Weight0.425 × Height0.725) × 0.007184.
The rest of body systems were examined and findings
recorded in the patient case note and the questionnaire.
Echocardiography
2D- and M-Mode echocardiography was performed
using a commercially available Philips/Agilent 5500
Sonos machine with a 3.25-MHz transducer, in subjects
in supine left lateral position and an average of 3
values/readings were taken as per the American Society
of Echocardiography (ASE) recommendations. The M-
mode derived parasternal view was used to assess for
the chamber and wall dimensions of the left ventricle
and left atrium, including the derived systolic indices
such as fractional shortening.
The ASE recommended formula-leading edge to leading
edge measurements-for estimation of Left Ventricular






LVIDd þ LVPWd þ IVSdð Þ3
 LVIDdð Þ3 þ 0:6g
Whereby,
1. LVPWd – posterior wall thickness at end diastole.
2. IVSd – septal wall thickness at end diastole.
3. LVIDd – dimensions of the left ventricle at end-
diastole
Gender-specific and indexation of left ventricular mas
(LVM) was used to diagnose LVH using the following
defining criteria: >115g/m2 and >95g/m2 for men and
women respectively when LVM was indexed to body
surface area (BSA) and >49.2g/m2.7 and 46.9 g/m2.7 for
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to allometric growth rate of 2.7. The relative wall thick-
ness (RWT) was calculated using the formula 2 ×
LVPWd/LVIDd. Increased RWT was present when this
ratio was >0.42 [5].
Left ventricular (LV) geometry was divided into four
patterns based on left ventricular mass index (LVMI)
and relative wall thickness (RWT) values. These are:
1. Normal geometry (NG) – normal LVMI and RWT
≤ 0.42,
2. Concentric hypertrophy (CLVH) – increased LVMI
and RWT > 0.42,
3. Eccentric hypertrophy (ELVH) – increased LVMI
and RWT ≤ 0.42,
4. Concentric remodelling (CR) – normal LVMI and
RWT > 0.42.
Statistical analysis
SPSS version 17.0 software (SPSS, Chicago, IL, USA) was
used in the analysis of the data. Continuous variables
were expressed as mean ± SD while categorical variables
were expressed as counts (percentages). Chi-square (χ2)
analysis was done to compare proportions. Logistic
regression was run to determine predictors of LVH. A 2-
tailed p-value of 0.05 was taken as statistically significant.
Ethical clearance and consent
This study was ethically approved by the Kilimanjaro
Christian Medical University College (KCMUCo)
Research Ethics Committee after meeting the required
ethical standards.
The principal investigator fully explained to every
prospective participant the purpose of the research and
was requested to participate freely. A consent form con-
taining details of the study regarding main purpose, roleTable 1 Clinical characteristics of hypertensive patients accor
Clinical parameter All (n=227)
Early (n=44)
Age (years ± SD) 61.0 ± 11.3 55.3 ± 10.9
Age group: < 50 years [n(%)] 38 (16.7) 14 (36.8)
Age group: 50 – 69 years [n(%)] 127 (55.9) 24 (18.9)
Age group: ≥70 years [n(%)] 62 (27.3) 6 (9.7)
Male sex [n(%)] 84 (37.0) 18 (21.4)
Female sex [n(%)] 143 (63.0) 26 (18.2)
BMI (kg/m2 ± SD) 27.6 ± 5.3 27.5 ± 5.1
BSA (m2 ± SD) 1.75 ± 0.17 1.79 ± 0.20
SBP (mmHg ± SD) 161.2 ± 19.08 157.7 ± 17.50
DBP (mmHg ± SD) 97.27 ± 10.41 98.64 ± 9.77
PP (mmHg ± SD) 63.88 ± 16.59 59.09 ± 4.28
MAP (mmHg ± SD) 118.56 ± 1.51 118.33 ± 0.99
BMI=Body Mass Index, BSA=Body Surface Area, SBP=Systolic Blood Pressure, DBP=Diaof participants, and benefits associated with participating
in the study (if any) was given to each prospective par-
ticipant. Those who agreed to participate in the study
gave a verbal consent as well as signing a written con-
sent form written both in English and Swahili language.
Swahili language is a lingua franca in Eastern Africa.
Patients who did not agree to participate in the study
were not denied any services or treated with partiality
and even those who agreed to be recruited in the study
were not treated differently from those who did not
agree to participate in the study.
Results
Clinical characteristics of hypertensive according to
duration of hypertension
As shown in Table 1, two hundred and twenty seven
hypertensive patients (84 males and 143 females) partici-
pated in this study. The mean age was 61years with
standard deviation of 11.3. The proportion of patients
according to duration of hypertension significantly
increased with age (p <0.001). Duration of hypertension
was arbitrarily defined as early it was present for less than
1 year, intermediate if it is diagnosed between 1 but less
than 5 years and long term if the hypertension was diag-
nosed and present for 5 years or more. Mean age of early
hypertension was 55.3 years, increasing to 59.6 years for
intermediate to 65.8 years for long-term hypertension.
Duration of hypertension was independent of sex, body
surface area, body mass index, systolic blood pressure,
diastolic blood pressure and mean arterial pressure.
Echocardiographic characteristics of hypertensive patients
according to duration of hypertension
As shown in Table 2, all mean values of echocardio-
graphic parameters were significantly influenced by du-
ration of hypertension as they increased in dimensionsding to duration of hypertension
Duration of hypertension p value
Intermediate (n=101) Long term (n=82)
59.6 ± 10.5 65.8 ± 10.8 <0.001
18 (47.4) 6 (15.8) <0.001
63 (49.6) 40 (31.5)
20 (32.3) 36 (58.1)
32 (38.1) 34 (40.5) 0.331
69 (48.3) 48 (33.6)
27.5 ± 5.6 27.8 ± 5.1 0.91
1.74 ± 0.16 1.73 ± 0.16 0.129
162.57 ± 8.09 161.22 ± 20.99 0.373
97.43 ± 11.46 96.34 ± 9.36 0.491
65.15 ± 16.53 64.88 ± 17.52 0.102
119.14 ± 11.66 11.97 ± 11.71 0.783
stolic Blood Pressure, PP=Pulse Pressure, MAP=Mean Arterial Blood Pressure.
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ventricular fractional shortening decreased with duration
of hypertension (p=0.003).
LV normal geometry was detected in 68 (30.0%) of the
227 hypertensive patients, concentric hypertrophy in 64
(28.2%), concentric remodelling in 45 (19.8%) and eccen-
tric hypertrophy in 50 (22.0%).LV geometrical patterns according to duration of
hypertension
In Table 3, it is shown that normal LV geometry was
present in majority of patients with early hypertension
28 (63.6%) while eccentric hypertrophy was least in
patients with intermediate hypertension (11.9%) and
highest in patients with long term hypertension (43.9%).
The difference between LV geometrical patterns and
duration of hypertension was significant (p<0.001).Clinical and echocardiographic characteristics of different
LV geometrical patterns
In Table 4, Normal geometry and concentric remodel-
ling LV patterns were present in patients with mean age
around 58 years while concentric hypertrophy and
eccentric hypertrophy patterns were present in patients
with mean age above 60 years. With increasing age,
abnormal LV geometrical patterns present itself in the
order of concentric remodelling then concentric hyper-
trophy to eccentric hypertrophy (p<0.001).
Normal geometry is more frequent in male than fe-
male (42.9% vs. 22.4%) while concentric remodelling and
concentric hypertrophy is more frequent in female than
male (23.1% vs. 14.3% and 33.6% vs. 19.0% respectively).
Eccentric hypertrophy did not differ much between male
and female (23.8% vs. 21.0%). The difference in presenta-
tion of LV geometrical patterns with sex is statistically






IVSWTd (cm) 1.20 ± 0.29 1.03 ± 0.26
LVPWTd (cm) 1.09 ± 0.27 0.95 ± 0.23
LVIDd (cm) 4.86 ± 0.46 4.73 ± 0.33
LVIDs (cm) 3.38 ± 0.50 3.21 ± 0.38
FS (%) 30.88 ± 5.53 32.41 ± 5.21
RWT(cm) 0.45 ± 0.11 0.40 ± 0.09
LVM(g) 218.40 ± 88.24 169.18 ± 72.95
LVMI-BSA (g/m2) 125.90 ± 52.95 94.59 ± 40.38
LVMI-height2.7 (g/m2.7) 61.56 ± 27.66 45.50 ± 21.81
IVSWTd = Inter-ventricular septal wall thickness at end-diastole, LVPWTd=Left ventr
diameter at end-diastole, LVIDs=Left ventricular internal diameter at end-systole, FS
mass, LVMI-BSA= Left ventricular mass indexed to body surface area, LVMI-height2.7Abnormal LV geometrical pattern presentation with
body mass index was present in patients who are at least
overweight (BMI >25kg/m2). Concentric hypertrophy was
present in patients who have higher mean BMI compared
to patients with concentric remodeling and eccentric
hypertrophy (29.72 vs. 27.20 and 27.60kg/m2 respectively).
Normal geometrical pattern was present in patients
who have relatively smaller BMI (25.97kg/m2) compared
to other geometrical patterns. The difference in body
mass index and LV geometrical pattern presentation was
significant (p=0.001).
There was a progressive increase in mean systolic,
diastolic and mean arterial blood pressure in patients
with normal geometry to patients with concentric hyper-
trophy, followed by decline in patients with eccentric
hypertrophy (p<0.05).
LV geometrical patterns presentation change with dur-
ation of hypertension significantly (p<0.001), being lower
in normal geometry and highest in eccentric hyper-
trophy (mean duration increased from 2.76 for normal
to 12.56 years for eccentric hypertrophy).
There was a significant difference regarding the inter-
ventricular septal wall thickness at end-diastole, left ven-
tricular posterior wall thickness at end diastole, relative
wall thickness, left ventricular mass indexed to body sur-
face are and height2.7 dimension presentation in different
LV geometrical patterns, increasing from normal through
concentric hypertrophy and then declining in eccentric
hypertrophy (p<0.001).
The left ventricular internal diameters during diastole
and systole were relatively higher in patients with normal
geometrical than with concentric remodelling patterns but
increased from patients with concentric remodeling to ec-
centric hypertrophy patterns. This difference was statisti-
cally significant (p<0.001).
The left ventricular fractional shortening was normal
for normal geometrical, concentric remodeling andients according to duration of hypertension





1.18 ± 0.29 1.32 ± 0.26 <0.001
1.09 ± 0.25 1.18 ± 0.27 <0.001
4.75 ± 0.41 5.07 ± 0.49 <0.001
3.27 ± 0.43 3.61 ± 0.56 <0.001
31.50 ± 5.22 29.29 ± 5.76 0.003
0.46 ± 0.09 0.47 ± 0.14 0.004
208.59 ± 90.93 256.95 ± 75.85 <0.001
120.39 ± 55.26 149.49 ± 45.32 <0.001
58.80 ± 29.22 73.59 ± 23.08 <0.001
icular posterior wall thickness at end-diastole, LVIDd=Left ventricular internal
= Fractional Shortening, RWT=Relative wall thickness, LVM=Left ventricular
= Left ventricular mass indexed to height2.7.






Duration of hypertension p value
Early (n=44) Intermediate (n=101) Long term (n=82)
NG [n(%)] 68 (30.0) 28 (63.6) 32 (31.7) 8 (9.8) <0.001
CR [n(%)] 45 (19.8) 10 (22.7) 27 (26.7) 8 (9.8)
CH [n(%)] 64 (28.2) 4 (9.1) 30 (29.7) 30 (36.6)
EH [n(%)] 50 (22.0) 2 (4.5) 12 (11.9) 36 (43.9)
NG=normal geometry, CR=concentric remodelling, CH=concentric hypertrophy, EC=Eccentric hypertrophy.
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mildly lower for patients with eccentric hypertrophy.
Clinical functional correlates of different LV geometrical
patterns
As shown in Table 5, regarding clinical functional
correlates of different LV geometrical patterns, chest
tightness, exertional dyspnoea, paroxysymal nocturnal
dyspnoea, lower limb oedema, palpitations and general
body fatigue were more common in patients with
eccentric hypertrophy and in patients with concentric
hypertrophy. These features were almost absent in
patients with concentric remodelling and normal LV
geometry. This difference was statistically significant






Age (years) 57.62 ± 9.93 57.53 ± 9.99
Male [n (%)] 36 (42.9) 12 (14.3)
Female [n(%)] 32 (22.4) 33 (23.1)
Age at diagnosis (years) 54.85 ± 10.09 54.02 ± 8.84
BMI (kg/m2) 25.97 ± 4.250 27.20 ± 4.99
BSA (m2) 1.74 ± 0.17 1.74 ± 0.15
DBP (mmHg) 94.71 ± 10.14 98.67 ± 1.40
SBP (mmHg) 150.59 ± 14.24 166.67 ± 16.65
MAP (mmHg) 113.33 ± 8.43 121.33 ± 11.53
HTN duration (years) 2.76 ± 4.33 3.51 ± 3.32
IVSWTd (cm) 0.96 ± 0.13 1.05 ± 0.11
LVPWTd (cm) 0.87 ± 0.08 1.02 ± 0.10
LVIDd (cm) 4.76 ± 0.29 4.35 ± 0.21
LVIDs (cm) 3.23 ± 0.39 2.98 ± 0.27
FS 32.53 ± 5.30 31.53 ± 4.92
RWT (cm) 0.37 ± 0.04 0.47 ± 0.04
LV mass (g) 150.00 ± 25.39 153.20 ± 19.71
LVMI-BSA (g/m2) 86.59 ± 14.80 88.56 ± 11.22
LVMI-height2.7 (g/m2.7) 40.32 ± 7.97 42.47 ± 5.41
HTN=hypertension, BMI=Body Mass Index, BSA=Body surface area, DBP=Diastolic b
IVSWTd=Interventricular septal wall thickness at end-diastole, LVPWTd=LV posterior
diastole, LVIDs=LV internal diameter at end-systole, FS=fractional shortening, RWT=
Surface Area, LVMI-height 2.7=left ventricular mass indexed to height 2.7.Determinants of left ventricular hypertrophy in
hypertensive patients
As is shown in Table 6, the independent determinants of
LVH after a step wise logistic regression analysis were
age of the patient, systolic blood pressure, duration of
hypertension and body mass index.
Discussion
In this study abnormal LV geometry was detected in
70% of patients while Aje [11] found 72% of newly diag-
nosed hypertensive patients to have abnormal LV geom-
etry. Akintunde [12] found abnormal LV geometry in
72% of treated hypertensive patients. In this study, the
distribution of different abnormal LV geometrical pat-
terns was 19.8%, 28.2%, 22% for concentric remodeling,rent LV geometrical patterns
lar geometrical patterns p value
Concentric hypertrophy Eccentric hypertrophy
61.19 ± 11.79 68.44 ± 10.25 <0.001
16 (19.0) 20 (23.8) 0.003
48 (33.4) 30 (21.0)
55.17 ± 12.33 55.88 ± 11.13 0.865
29.72 ±6.01 27.60 ±5.206 0.001
1.78 ± 0.19 1.74 ± 0.15 0.581
100.62 ± 10.97 95.20 ± 7.62 0.003
169.69 ± 20.39 159.60 ± 18.40 <0.001
123.65 ± 12.83 116.67 ± 10.034 <0.001
6.02 ± 4.37 12.56 ± 8.41 <0.001
1.59 ± 0.21 1.18 ± 0.14 <0.001
1.47 ± 0.16 0.98 ± 0.098 <0.001
4.90 ± 0.34 5.41 ± 0.30 <0.001
3.36 ± 0.41 3.96 ± 0.38 <0.001
31.72 ± 5.71 26.96 ± 4.27 <0.001
0.60 ± 0.08 0.36 ± 0.031 <0.001
326.12 ± 74.14 232.32 ± 25.38 <0.001
187.22 ± 51.72 134.48 ± 25.84 <0.001
94.47 ± 25.66 65.52 ± 13.37 <0.001
lood pressure, SBP=Systolic blood pressure, MAP=Mean arterial pressure,
left ventricular wall at end-diastole, LVIDd=LV internal diameter at end-
Relative wall thickness , LVMI-BSA=Left Ventricular mass indexed to Body
Table 5 Clinical functional correlates of different LV geometrical patterns
Clinical features Total
[(n%)]
LV geometrical pattern p value
NG CR CH EH
[n (%)] [n (%)] [n (%)] [n (%)]
Dyspnoea at rest 5 (2.2) 0 (0) 0 (0) 0 (0) 5 (100.0) <0.001
Chest tightness 13 (5.7) 2 (15.4) 0 (0) 1 (7.7) 10 (76.9) <0.001
Exertional dyspnoea 31 (13.7) 0 (0) 1 (3.2) 6 (19.4) 24 (77.4) <0.001
Paroxysmal nocturnal dyspnoea 13 (5.7) 0 (0) 0 (0) 3 (23.1) 10 (76.9) <0.001
Lower limb oedema 22 (9.7) 0 (0) 0 (0) 6 (27.3) 16 (72.7) <0.001
Palpitation 15 (6.6) 0 (0) 0 (0) 1 (6.7) 14 (93.3) <0.001
General body fatigue 32 (14.1) 4 (12.5) 0 (0) 8 (25) 20 (62.5) <0.001
NG=normal geometry, CR=concentric remodelling, CH=concentric hypertrophy, EH=eccentric hypertrophy.
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spectively. Aje [11] found the distribution of abnormal
LV geometry to be 26%, 28% and 18% for concentric re-
modeling, concentric hypertrophy and eccentric hyper-
trophy respectively, while Akintunde [12] found the
distribution to be 60.1%, 5.3% and 6.9% for concentric
remodeling, eccentric hypertrophy and concentric
hypertrophy respectively. The variation can partly be
explained by difference in echocardiographic cut-off
values for defining LVH and intrinsic population charac-
teristics of a given geographical location.
Duration of hypertension markedly influenced the type
of LV geometry with normal LV geometry predominating
in early hypertension and abnormal geometrical patterns
predominating in late hypertension, as is found also by
Akintunde [12]. During hypertension the various cardiacTable 6 Determinants of left ventricular hypertrophy in hype
Variables
B S.E. Wald
Step 1a HTN duration 0.209 0.035 35.435
Constant −1.138 0.22 26.752
Step 2b SBP 0.032 0.009 13.841
HTN duration 0.22 0.036 37.238
Constant −6.363 1.441 19.492
Step 3c SBP 0.033 0.009 13.151
HTN duration 0.227 0.037 37.031
BMI 0.112 0.032 12.476
Constant −9.669 1.843 27.514
Step 4d Age 0.049 0.017 8.06
SBP 0.032 0.009 11.48
HTN duration 0.202 0.037 29.632
BMI 0.147 0.036 17.129
Constant −13.343 2.453 29.582
HTN duration=duration of hypertension, SBP=systolic blood pressure, DBP=diastolic
a. Variable(s) entered on step 1: duration of Hypertension.
b. Variable(s) entered on step 2: Systolic blood pressure.
c. Variable(s) entered on step 3: Body mass Index.
d. Variable(s) entered on step 4: age.morphological adaptations occur depending on the pre-
dominating stimuli. The type of LV geometry relates to
the duration of hypertension and age of the patient
mostly depending on the predominating type of stimuli
i.e. pressure overload in early relatively ‘younger’ hyper-
tensive patients while volume overload predominate in
late and relatively ‘elderly’ hypertensive patients.
With regard to LVH, age of the patient, systolic blood
pressure, duration of hypertension and body mass index
were strong independent determinants of LVH. This was
also shown in a Russian study [6].
Regarding blood pressure and duration of hypertension,
there was significant change characterized by progressive
increase in mean systolic, mean diastolic and mean arterial
blood pressure from patients with normal geometry to
patients with concentric hypertrophy, followed by declinertensive patients
Df p-value Exp(B) 95.0% C.I.for EXP(B)
Lower Upper
1 0 1.233 1.151 1.321
1 0 0.321
1 0 1.032 1.015 1.05
1 0 1.246 1.161 1.338
1 0 0.002
1 0 1.033 1.015 1.052
1 0 1.255 1.166 1.35
1 0 1.118 1.051 1.19
1 0 0
1 0.005 1.05 1.015 1.086
1 0.001 1.032 1.014 1.052
1 0 1.224 1.138 1.316
1 0 1.159 1.081 1.242
1 0 0
blood pressure, BMI=body mass index.
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The studied echocardiographic parameters i.e. the inter-
ventricular septal wall thickness at end-diastole, left ven-
tricular posterior wall thickness at end diastole, relative
wall thickness, left ventricular mass indexed to body sur-
face and height2.7 increased significantly from normal
through concentric hypertrophy and then declining in ec-
centric hypertrophy.
This is because in patients with concentric remodeling
or concentric hypertrophy usually the pressure overload
predominates rather than volume overload stimuli. With
pressure overload the wall tension is high trying to coun-
teract the high peripheral resistance and usually the cardiac
myocyte hypertrophy typical of concentric hypertrophy.
With time, the hypertrophied cardiac muscle becomes
maladapative and fatigues for reasons not known and so to
overcome the volume overload the chambers dilate and
cardiac output is decreased and resultant reduced systolic
and diastolic pressure in eccentric hypertrophy.
Conclusions
About 70% of hypertensive patients at KCMC which is a ter-
tiary hospital in northern Tanzania had abnormal LV geom-
etry, whereby 19.8% had concentric remodelling, 28.2%
concentric hypertrophy and 22% eccentric hypertrophy.
The left ventricular systolic function by fractional
shortening was worse in patients with eccentric hyper-
trophy who were also more likely to have clinical fea-
tures of heart failure than patients with other types of
geometrical patterns.
Hypertensive patients are not a homogenous popula-
tion and characterization into different left ventricular
phenotypes is important to stage an appropriate ma-
nagement and monitor prognosis.
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